Receptor

Ligand binding to receptor proteins functions in signal transduction.

receptor proteins

Biologically active molecules (ligands) exert their physiological effect by activating or inducing 3D conformational changes in receptor proteins, which participate in signal transduction, cellular signaling, gene regulation, cellular proliferation and differentiation, or regulation of cellular metabolic processes.

Right - click to enlarge - Cartoon representation of a complex between DNA and the ZIF268 protein, containing 3 zinc finger motifs. The coordinating residues of the middle zinc finger are highlighted. Based on the x-ray structure of PDB 1A1L. Color coding: ZIF268: blue; DNA: orange; Zinc ions: green Author: Thomas Splettstoesser Download high-resolution version (1188x1114, 410 KB)

Receptor proteins are located in the cytoplasm, cell membrane, or nuclear membrane.
1. Cytoplasmic receptor proteins include those that respond to steroid hormones. Ligand activated receptors may enter the cell nucleus where they modulate gene expression.
2. Receptors within cell membranes may be peripheral or trans-membrane proteins. Many receptors for hormones and neurotransmission are trans-membrane proteins.
_a. Metabotropic receptors are coupled to G proteins, acting through various secondary pathways involving ion channels, enzymes such as adenylyl (adenylate) cyclases, and phospolipases, or PDZ domains.
_b. Ionotropic receptors are ligand-activated ion channels that permit entry of ions when the central pore is open.

active transportion channels [] image - receptor proteins [] 3D image steroid receptor - Zn finger Џ animation - receptor protein :

There are more than 1200 individual human plasma membrane receptors in more than 20 families. Examples of receptor proteins/receptors include:
a. Guanine nucleotide-binding protein-coupled receptors (GPCRs) (metabotropic).
b. serine threonine kinases (SerThr Kinase) : TGF-β; MAPK cascade; phosphoinositol kinase-related kinase (PIKK) family - mTOR (FRAP1), ATM, ATR, DNA-PK
c. receptor tyrosine kinases (RTKs) : EGFR, Tie receptors, Eph RTKs,
d. cytokine receptors
e. integrins
f. TNF receptors : FAS

Џ beautiful Flash 8 animation - Inner Life of the Cell, which shows membrane adhesion-signaling, and Interpretation: Inner Life of the Cell Џ

• A • adhesion • C • cell membranescellular adhesion moleculescellular signal transductioncentrioleschemotaxischloroplastcilia & flagellacommunicationconcentration gradientscytokine receptorscytoplasmcytoskeleton • E • energy transducersendoplasmic reticulumendosomesexosome • F • flagella & cilia • G • Golgi apparatusGPCRs • H • hormones • I • ion channels • L • lysosome • M • meiosismicrotubulesmitosismitochondrion • N • Nitric Oxideneurotransmissionneuronal interconnectionsnuclear membranenuclear pore • P • pinocytosisproteasomeprotein degradationpumps • R • receptor proteinsreceptor-mediated endocytosis • S • second messengerssignaling gradientssignal transductionspindlestructure • T • transporttwo-component systems • U • ubiquitin • V • vacuolevesicle

. 7 TM receptors & GPCRs . Toll . NPR . Integrins . LDL receptors & LRP . Notch . Patched Plexins . Roundabout . RPTPs . RTKs . Ser/Thr Kinase receptors . TNF receptors . Cytokine 1 receptors . T-cell receptors . Cytokine 2 receptors . Netrin receptors .

Labels: , , , , , , , ,

| 0 Guide-Glossary

receptor tyrosine kinases

Receptor tyrosine kinases (RTKs) are involved in signal transduction, and process a variety of environmental and intercellular cues. By contrast, protein tyrosine kinases (PTKs) are non-receptor enzymes that catalyze the phosphorylation of tyrosine residues. Of the 91 protein tyrosine kinases identified, 59 are receptor tyrosine kinases and 32 are non-receptor, cellular tyrosine kinases. More than 70% of known oncogenes (cancers) and proto-oncogenes (development) code for PTKs.

: ABL : BTK : cellular protein tyrosine kinases : CSK : EGFR : extracellular domains : FAK & focal adhesion kinase : FPS : JAK : PTKs : Ras : receptor tyrosine kinases, RTKs : RTK functions : SFKs : STATs : SYK : tumors :

As central components of cell signaling networks, RTKs play crucial play crucial roles in physiological processes, such as embryogenesis, differentiation, neurite outgrowth, cell proliferation, anti-apoptotic signaling and death of cells (apoptosis). Some signaling molecules act as adhesion receptors, which cluster in focal adhesions upon ligand binding. Focal adhesions are rich in tyrosine phosphorylated proteins, coupling cell adhesion to signal transduction pathways in the cell. Various adhesion receptors, such as integrins, are closely linked to protein kinases and phosphatases.

RTKs comprise four domains:
1. extracellular ligand binding domain.
2. intracellular tyrosine kinase domain, with amino acid sequences in ATP binding and substrate binding regions highly conserved with those of cAMP-dependent protein kinase (cAPK, PKA).
3. intracellular regulatory domain.
4. transmembrane domain.

RTKs are anchored in the plasma membrane at the transmembrane domain, while the extracellular domains bind growth factors. Typically, extracellular domains comprise structural motifs including acidic regions, cadherin-like domains, cysteine-rich regions, discoidin-like domains, EGF-like domains, Factor VIII-like domains, fibronectin III-like domains, glycine-rich regions, immunoglobulin-like domains, kringle-like domains, and leucine-rich regions.

Tables  Receptor Tyrosine Kinases(RTK)  Cell signaling  Cell Adhesion Molecules  Immune Cytokines  Receptor Signal Transduction  Second Messengers 

The intracellular kinase domains of receptor PTKs (RTKs) are divided into two classes:
a) those containing a stretch of amino acids separating the kinase domain, and
b) those in which the kinase domain is continuous.

Activation of the kinase is effected by binding of a ligand to the extracellular domain, which induces dimerization of the receptors. Activated receptors autophosphorylate tyrosine residues outside the catalytic domain via cross-phosphorylation. This auto-phosphorylation stabilizes the active receptor conformation and creates phosphotyrosine docking sites for proteins that transduce signals within the cell.

The epidermal growth factor (EGFR) family of receptor tyrosine kinases comprises four receptors: EGF-R (ErbB1), ErbB2 (Neu), ErbB3, and ErbB4.

Signaling proteins that bind to the intracellular domain of receptor tyrosine kinases in a phosphotyrosine-dependent manner include RasGAP, PI3-kinase, phospholipase C , phosphotyrosine phosphatase SHP and adaptor proteins such as Shc, Grb2 and Crk. Grb2 links focal adhesion kinase (FAK) to the Ras pathway when Grb2 is phosphorylated after binding to FAK. The 85 kDa subunit of the PI 3-kinase is also phosphorylated after binding to FAK. Thus, FAK is a key component in the assembly of focal contact structures that influence cytoskeletal organization and signal transduction. [] 3D phospholipase-C /PDGF-receptor [] inactive and active Ras molecular switch []

In contrast to receptor-PTKs (RTKs), cellular PTKs are located in the cytoplasm, the nucleus, or are anchored to the inner leaflet of the plasma membrane. Cellular PTKs are grouped into eight families: SRC, JAK, ABL, FAK, FPS, CSK, SYK and BTK, each with several members. Except for homologous kinase domains (Src Homology 1, or SH1 domains), and some protein- protein interaction domains (SH2 and SH3 domains), the PTK families share little structurally. Of the cellular PTKs with known functions, many, such as SRC, are involved in cell growth. FPS PTKs are involved in cellular differentiation, ABL PTKs participate in growth inhibition, and FAK activity is associated with cell adhesion. Some members of the cytokine receptor pathway interact with JAKs, which phosphorylate the transcription factors, STATs.

PTKs are hyperactivated in several human solid tumors and hematological malignancies, and elevated levels contribute to tumourigenesis factors such as hyperplasia, survival, invasion, metastasis and angiogenesis. PTKs of the Src family (SFKs) are activated and overexpressed in approximately 80% of colon tumors; EGFR family PTKs are overexpressed/activated in the most breast and lung carcinomas and primary glioblastomas; and, EpH receptor PTKs are overexpressed in most melanomas.

* A ligand is any molecule that binds reversibly and specifically to a protein. In the case of protein transcription factors, the ligand is DNA. receptor proteins

Tables  Receptor Tyrosine Kinases(RTK)  Cell signaling  Cell Adhesion Molecules  Immune Cytokines  Receptor Signal Transduction  Second Messengers 

phosphotransfer-mediated signaling pathwaysProtein Kinase Signaling Networksreceptor tyrosine kinases •  Receptor Tyrosine Kinases (RTKs)signaling gradientstwo-component systems • animation MAPK signal transduction : animation G-protein :: ABL : BTK : cellular protein tyrosine kinases : CSK : EGFR : extracellular domains : FAK & focal adhesion kinase : FPS : JAK : PTKs : Ras : receptor tyrosine kinases, RTKs : RTK functions : SFKs : STATs : SYK : tumors :

Syk tyrosine kinase and Src homology (SH) 2 domain-containing leukocyte-specific phosphoprotein of 76 kDa (SLP-76) are critical signaling mediators activated downstream of both immunoreceptor tyrosine-based activation motif (ITAM)-containing immunoreceptors and integrins.[r]

Signaling pathways:
Pathway ABC transporters : Pathway Phosphotransferase system (PTS) : Pathway Two-component system : Pathway MAPK signaling pathway : Pathway Wnt signaling pathway : Pathway Notch signaling pathway : Pathway Hedgehog signaling pathway : Pathway TGF-beta signaling pathway : Pathway VEGF signaling pathway : Pathway Jak-STAT signaling pathway : Pathway Calcium signaling pathway : Pathway Phosphatidylinositol signaling system : Pathway mTOR signaling pathway : Pathway Neuroactive ligand-receptor interaction : Pathway Cytokine-cytokine receptor interaction : Pathway ECM-receptor interaction : Pathway Cell adhesion molecules (CAMs) :

: Evolution of Protein Kinase Signaling : ▲ Top

Labels: , , , , , , , , , , , , ,

| 0 Guide-Glossary

signal transduction

Cellular signal transduction involves the conversion of one signal or stimulus (mechanical or chemical) to another. The transduction process is usually performed by enzymes in association with second messengers.

▼ : 7TM receptors : classes of receptors : controlled activities : coupling : DAG : diacylglycerol : DGKzeta : extracellular signals : GEFs : G-protein coupled receptors : guanine nucleotide-binding protein-coupled receptors : GPCR families : GPCRs : heptahelical receptors : hormone receptors : HREs : intracellular signals : intracellular receptors : intercellular signals : IP3 : kinase inhibitors : ligands : phospholipases : phospholipids : PI3K : PKCs : protein kinases : Ras : RasGRP : receptor classes : serpentine receptors : targets for control : 7TM receptors : ▼

Extracellular signals impinge upon specialized membranous receptors. Sensory transduction involves the conversion of mechanical or chemical stimuli to cellular signals or neurophysiological signals. Intracellular signals enable communication within cells, while intercellular signals enable communication between cells.

Tables  Cell Adhesion Molecules  Cell signaling  Immune Cytokines  Receptor Tyrosine Kinases (RTKs)  Second Messengers 

Chemical signals (ligands) include :
1. neurotransmitters : acetylcholine, dopamine, epinephrine, GABA, glycine, norepinephrine, serotonin (5HT), etc.
2. hormones
3. phospholipids
4. growth factors
5. nutrients

Classes of receptors:
1. Membrane-penetrating receptors possessing/connected to intrinsic enzymatic activity:
…….a) receptor tyrosine kinases (RTKs) capable of autophosphorylation as well as phosphorylation of other substrates (incl. EGF, FGF, insulin, PDGF receptors),
…….b) tyrosine phosphatases (CD45),
…….c) guanylate cyclases (natriuretic peptide receptors),
…….d) serine/threonine kinases (activins, inhibins, bone morphogenetic proteins (BMPs), TGF-beta receptors).
…….e) receptors coupled to intracellular tyrosine kinases by direct protein-protein interactions: 'Multiprotein signaling networks create focal points of enzyme activity that disseminate the intracellular action of many hormones and neurotransmitters. Accordingly, the spatio-temporal activation of protein kinases and phosphatases is an important factor in controlling where and when phosphorylation events occur. Anchoring proteins provide a molecular framework that orients these enzymes towards selected substrates. A-kinase anchoring proteins (AKAPs) are signal-organizing molecules that compartmentalize the cAMP dependent protein kinase, phosphodiesterases, and a variety of enzymes that are regulated by second-messengers.'[s].

Phospholipases and phospholipids participate in transmission of ligand-receptor induced signals from the plasma membrane to intracellular proteins, primarily PKC, which is maximally active in the presence of calcium ion and diacylglycerol. PKC activity is mediated by receptors that are coupled to activation of phospholipase C-gamma (PLC-gamma), which contains SH2 domains that enable it to interact with tyrosine phosphorylated RTKs. PI-3K is tyrosine phosphorylated and activated by various RTKs and receptor-associated PTKs. PI-3K is activated by the PDGF, EGF, insulin, IGF-1, HGF and NGF receptors. The p85 subunit of PI-3K is activated by tyrosine phosphorylation, but only the 110 kDa subunit is enzymatically active.

Phospholipases D and A2 (PLD, PLA2) sustain the activation of PKC through their hydrolysis of membrane phosphatidylcholine (PC). Activation of PLC-gamma results in hydrolysis of membrane phosphatidylinositol bisphosphate (PIP2), which leads to an elevation of intracellular DAG and inositol trisphosphate (IP3), which interacts with intracellular membrane receptors to effect release of stored calcium ions (PKC is maximally active in the presence of second messengers, calcium ions and diacylglycerol).

Diacylglycerol (DAG) is an intracellular messenger, which accumulates transiently in cells exposed to growth factors or other stimuli. Cellular responses such as growth and differentiation are impacted by the binding of DAG to PKC, thus activating PKC. Diacylglycerol kinases (DGKs) are responsible for eliminating the function of diacylglycerol (DAG) and for producing phosphatidic acid (PA) (both molecules are connected to cancer).

DGKzeta regulates factors that promote activity of the oncogene product, Ras, the activity of which must be precisely regulated lest abnormal cellular proliferation result. An estimated 30% of human tumors have an activating mutation of the Ras gene. Guanine nucleotide exchange factors (GEFs) activate Ras by facilitating GTP binding. Abnormally high levels of the nucleotide exchange factor, RasGRP can lead to malignant transformation. RasGRP has a diacylglycerol (DAG)-binding domain and its exchange factor activity depends on local availability of the signaling molecule DAG. Diacylglycerol kinases (DGKs) remove DAG from the cell by converting DAG to PA. DGKzeta, but not other DGKs, can completely eliminate Ras activation induced by RasGRP, and diacylglycerol kinase activity is required for this mechanism.

2. Serpentine receptors, guanine nucleotide-binding protein-coupled receptors, or GPCRs, in which a characteristic trans-membrane structure spans the cell membrane seven times. Intracellular signalling is carried out by association of the neurotransmitter with G-proteins (small GTP-binding and hydrolyzing proteins), which leads to generation of second messengers. GTP-hydrolytic activity of G-proteins is regulated by GTPase activating proteins, GAPs. Ras, is a proto-oncogenic G-protein involved in carcinogenesis. Other cancer-active G-proteins include the gene products of the neurofibromatosis type-1 (NF1) susceptibility locus and the BCR locus (break point cluster region gene).

There are several families of GPCRs, including:
(a) GPCRs that modulate adenylate cyclase activity
(b) GPCRs that activate phospholipase C-gamma, leading to hydrolysis of polyphosphoinositides (such as PIP2) and generating the second messengers, diacylglycerol (DAG) and inositol trisphosphate (IP3). This class of receptors includes receptors for angiotensin, bradykinin and vasopressin.
(c) Photoreceptors coupled to a G-protein (transducin) that activates a phosphodiesterase, depressing the level of second messenger cGMP. The drop in cGMP causes closing of a Na+/Ca2+ ion channel, leading to hyperpolarization of the cell.

3. Intracellular receptors that migrate to the nucleus after binding to the ligand – here the ligand-receptor complex directly affects gene transcription. Hormone receptors are cytoplasmic proteins that bypass membrane-bound signal transduction pathways – receptors for lipophilic steroid/thyroid hormones, the glucocorticoid, vitamin D, retinoic acid and thyroid hormones. All hormone receptors are capable both of binding hormone and of directly activating gene transcription (bi-directional). After binding the hormonal ligand, the hormone-receptor complex translocates to the nucleus and binds to specific DNA sequences (hormone response elements, HREs), resulting in altered transcription rates of the associated gene.

Coupling of ligand-receptor interactions to intracellular events
1. phosphorylations by tyrosine kinases and/or serine/threonine kinases – two-component systems

Intracellular events controlled by signaling:
1. gene expression (transcription)
2. chemotaxis
3. cellular growth, proliferation, and differentiation (tyrosine and serine/threonine phosphorylation)

Protein kinases are targetted by pharmaceuticals because PKs play a variety of roles in disease states. Kinase inhibitors bind to the kinase in at least four different binding modes:
(1) direct competition with ATP at the ATP binding site;
(2) engagement of an adjacent allosteric binding site in the ATP pocket, which is usually accessible when the activation loop is in the inactive conformation; and
(3) binding at sites remote from the ATP site (but still close to the ATP) that impact kinase activity;
(4) binding outside of the ATP binding pocket (truly allosteric).

Kinases can escape inhibition by mutating key residues in their catalytic domain, thus becoming resistant to the kinase inhibitors. Those kinase that have or gain functional mutations may be more sensitive or resistant to inhibition by kinase inhibitors than is the wt form of the kinase.

▲: 7TM receptorsadhesioncell membraneschemotaxis : classes of receptors : controlled activities : coupling : DAG ~ DAG ~ DAGKs ~ diacylglycerol ~ diacyl glycerol kinase : diacylglycerol : DGKzeta : extracellular signals : GEFs : G-protein coupled receptors : guanine nucleotide-binding protein-coupled receptors : GPCR families : GPCRsGPCRsGPCR families s : heptahelical receptorshormones: hormone receptors : HREs : intracellular signals : intracellular receptors : intercellular signals : IP3 : kinase inhibitors : ligandsmicrotubulesmigrationmolecular switchesneurotransmissionneuronal interconnections : phospholipases ~ phospholipase C-gamma : phospholipids : PI3K : PKCs : protein kinases : Ras : RasGRP ¤ Ras : receptor classesreceptor-mediated endocytosisreceptor proteins : serpentine receptors ~ signaling items ¤ signaling molecules : targets for control : 7TM receptors : ▲

ChemotaxisGPCRsGPCR familieshormonesneurotransmissionNitric Oxideneuronal interconnectionsphosphotransfer-mediated signaling pathwaysProtein Kinase Signaling Networksreceptor tyrosine kinases •  Receptor Tyrosine Kinases (RTKs) Tables  Cell signaling  Cell Adhesion  Second Messengers  Immune Cytokines  Apoptosis vs Necrosis  Apoptosis  Malignant Transformation  Oncogenes Proto-oncogenes  Regulatory Proteins Sequences  • signaling gradientstwo-component systems • animation MAPK signal transduction : more :

Signaling pathways:
Pathway ABC transporters : Pathway Phosphotransferase system (PTS) : Pathway Two-component system : Pathway MAPK signaling pathway : Pathway Wnt signaling pathway : Pathway Notch signaling pathway : Pathway Hedgehog signaling pathway : Pathway TGF-beta signaling pathway : Pathway VEGF signaling pathway : Pathway Jak-STAT signaling pathway : Pathway Calcium signaling pathway : Pathway Phosphatidylinositol signaling system : Pathway mTOR signaling pathway : Pathway Neuroactive ligand-receptor interaction : Pathway Cytokine-cytokine receptor interaction : Pathway ECM-receptor interaction : Pathway Cell adhesion molecules (CAMs) : Orthology Transporters (+diseases) : Orthology Two-component system : Orthology Receptors and channels (+diseases) : Orthology Cytokines : Orthology Cell adhesion molecules (CAMs) : Orthology CAM ligands : Orthology CD molecules : Orthology GTP-binding proteins :

Top

Labels: , , , , , , , , , , ,

| 0 Guide-Glossary

... receiving visitors since 12/21/06